Distrobird — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free
Bioxytran, Inc.
bioxytran, inc., an early stage pharmaceutical company, focuses on the development, manufacture, and commercialization of various therapeutic drugs to address hypoxia in humans. the company's lead pharmaceutical drug candidate is bxt-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for the treatment of patients with ischemia of the brain resulting from a stroke or the blockage of the blood vessels to the brain. its products also include bxt-252, an injectable anti-necrosis drug to treat a wound that does not heal because limited amount of oxygen reaching the wound. the company was founded in 2017 and is headquartered in newton, massachusetts.
Frequently asked questions about Bioxytran, Inc.
Let us help answer the most common questions you might have.
What is Bioxytran, Inc.'s official website?
Bioxytran, Inc.'s official website is bioxytraninc.com
How many employees does Bioxytran, Inc. have?
Bioxytran, Inc. has 1 employee
What industry does Bioxytran, Inc. belong to?
Bioxytran, Inc. is in the industry of: Medical Devices
Distrobird — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free